3 Branded Medicine, Blue Pigment and Rice Exporter Stocks With a Strong Future Roadmap: Alkem Laboratories, Ultramarine & Pigments and LT Foods
- October 16, 2026
- Posted by: Neeraj Pandey
- Category: Best Stocks
Alkem Rs 5,120.50, P/E 28.43. Ultramarine Rs 392.70, P/E 12.67. LT Foods Rs 419.60, P/E 21.98. Closing prices of 14 Oct 2026.
Quick Answer
Branded medicine, blue pigment and rice exporter stocks with the clearest long-term roadmaps today include Alkem in branded generics in India along with generic exports and a presence in international markets, Ultramarine in ultramarine blue pigments and related colourants for plastics, paints and detergents and LT Foods in basmati rice and packaged foods sold under brands such as Daawat. FY26 revenue growth was 13.7% at Alkem, 11.2% at Ultramarine and 25.7% at LT Foods. P/E stands at 28.43 for Alkem (industry 37.59), 12.67 for Ultramarine (industry 36.60) and 21.98 for LT Foods (industry 34.85). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company’s risks need equal attention.
Branded medicine, blue pigment and rice exporter stocks give investors exposure to medicines, colourants and food staples sold at home and abroad. Volumes, export demand and margins decide how much of that demand turns into profit.
This list covers three branded medicine, blue pigment and rice exporter stocks: Alkem Laboratories for branded generics in India along with generic exports and a presence in international markets, Ultramarine & Pigments for ultramarine blue pigments and related colourants for plastics, paints and detergents and LT Foods for basmati rice and packaged foods sold under brands such as Daawat. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.
Click Here – Get Free Investment Predictions
What Are Branded Medicine, Blue Pigment and Rice Exporter Stocks?
Branded medicine, blue pigment and rice exporter stocks are shares of companies that make health products, chemicals or run restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.
Branded Medicine, Blue Pigment and Rice Exporter Stocks at a Glance
The table compares size, valuation, return on equity and debt for the three branded medicine, blue pigment and rice exporter stocks as of the 14 Oct 2026 close.
| Company | CMP (Rs) | Market Cap (Rs Cr) | P/E | Industry P/E | ROE | Debt to Equity |
|---|---|---|---|---|---|---|
| Alkem Laboratories | 5,120.50 | 62,663 | 28.43 | 37.59 | 16.66% | 0.15 |
| Ultramarine & Pigments | 392.70 | 1,168 | 12.67 | 36.60 | 9.29% | 0.10 |
| LT Foods | 419.60 | 14,072 | 21.98 | 34.85 | 13.83% | 0.36 |
Among healthcare, chemicals and consumer stocks, all three trade at a discount to their industry P/E multiples.
Why Do Branded Medicine, Blue Pigment and Rice Exporter Stocks Have a Strong Roadmap in India?
Branded medicine, blue pigment and rice exporter stocks have a strong roadmap in India because doctor-prescribed brands, detergent and paint output and premium rice exports keep adding volumes for these firms. Three drivers stand out.
- Branded generics: Doctors prescribe trusted brands across therapies.
- Industrial colour: Detergents, plastics and paints use pigments.
- Premium food: Shoppers choose branded basmati at home and abroad.
Alkem Laboratories: Domestic Brands and Generics Drive the Pipeline
Alkem’s roadmap rests on branded generics in India along with generic exports and a presence in international markets, with a mix of domestic brands and exports supporting earnings.
Revenue grew from Rs 10,796.84 crore in FY22 to Rs 15,295.62 crore in FY26, a 41.7% rise, and FY26 revenue was 13.7% higher than FY25. FY26 net profit rose 6.2% to Rs 2,353.13 crore. Over four years, net profit rose from Rs 1,680.32 crore in FY22 to Rs 2,353.13 crore. In Q1 FY27, revenue grew 11.0% to Rs 3,892.90 crore. Operating margin was 23.20% in FY26.
Debt to equity is 0.15 and return on equity is 16.66%. FY26 operating cash flow was Rs 1,963.03 crore against capital expenditure of Rs 617.26 crore. Alkem paid a dividend of Rs 53 per share for FY26, a yield of 1.01%. At a P/E of 28.43 against an industry P/E of 37.59, the stock trades below its industry multiple.
What to watch: The P/E of 28.43 against an industry P/E of 37.59 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Ultramarine & Pigments: Pigments for Plastics and Paints Drive the Pipeline
Ultramarine’s roadmap rests on ultramarine blue pigments and related colourants for plastics, paints and detergents, with steady industrial demand supporting volumes.
Revenue grew from Rs 499.48 crore in FY22 to Rs 786.41 crore in FY26, a 57.4% rise, and FY26 revenue was 11.2% higher than FY25. FY26 net profit rose 7.6% to Rs 80.77 crore. Over four years, net profit rose from Rs 58.30 crore in FY22 to Rs 80.77 crore. In Q1 FY27, revenue grew 31.2% to Rs 245.68 crore, and net profit rose 56.5% to Rs 31.59 crore. Operating margin was 17.91% in FY26 and 21.33% in Q1 FY27 against 18.78% a year earlier.
Debt to equity is 0.10 and return on equity is 9.29%. FY26 operating cash flow was Rs 128.27 crore against capital expenditure of Rs 67.87 crore. Ultramarine paid a dividend of Rs 6 per share for FY26, a yield of 1.50%. At a P/E of 12.67 against an industry P/E of 36.60, the stock trades below its industry multiple.
What to watch: Q1 FY27 operating margin was 21.33% against 17.91% for FY26, so margin stability is the figure to follow as volumes grow.
LT Foods: Basmati and Packaged Foods Anchor the Roadmap
LT Foods’ roadmap rests on basmati rice and packaged foods sold under brands such as Daawat, with exports and branded sales supporting revenue.
Revenue grew from Rs 5,450.58 crore in FY22 to Rs 11,023.06 crore in FY26, a 102.2% rise, and FY26 revenue was 25.7% higher than FY25. FY26 net profit rose 2.2% to Rs 625.38 crore. Over four years, net profit rose from Rs 309.20 crore in FY22 to Rs 625.38 crore. In Q1 FY27, revenue grew 26.4% to Rs 3,161.29 crore, and net profit rose 8.9% to Rs 183.45 crore. Operating margin was 11.35% in FY26.
Debt to equity is 0.36 and return on equity is 13.83%. FY26 operating cash flow was Rs 910.50 crore against capital expenditure of Rs 359.62 crore. LT Foods paid a dividend of Rs 3 per share for FY26, a yield of 0.74%. At a P/E of 21.98 against an industry P/E of 34.85, the stock trades below its industry multiple.
What to watch: The P/E of 21.98 against an industry P/E of 34.85 leaves valuation less stretched, so the next quarters’ growth is the figure to follow.
Best Branded Medicine, Blue Pigment and Rice Exporter Stocks in India: Alkem vs Ultramarine vs LT Foods on Key Financials
Among the best branded medicine, blue pigment and rice exporter stocks in India, Alkem leads on FY26 operating margin and return on equity; Ultramarine leads on Q1 FY27 revenue growth and FY26 net profit growth; LT Foods leads on FY26 revenue growth. The table puts the numbers side by side.
| Metric | Alkem | Ultramarine | LT Foods |
|---|---|---|---|
| FY26 revenue (Rs Cr) | 15,295.62 | 786.41 | 11,023.06 |
| FY26 revenue growth | 13.7% | 11.2% | 25.7% |
| FY26 net profit (Rs Cr) | 2,353.13 | 80.77 | 625.38 |
| FY26 net profit growth | 6.2% | 7.6% | 2.2% |
| FY26 operating profit margin | 23.20% | 17.91% | 11.35% |
| Q1 FY27 revenue growth (YoY) | 11.0% | 31.2% | 26.4% |
| Return on equity | 16.66% | 9.29% | 13.83% |
| P/E ratio | 28.43 | 12.67 | 21.98 |
| Debt to equity | 0.15 | 0.10 | 0.36 |
| Dividend yield | 1.01% | 1.50% | 0.74% |
| FY26 operating cash flow (Rs Cr) | 1,963.03 | 128.27 | 910.50 |
Healthcare, chemicals and food earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.
How to Evaluate Branded Medicine, Blue Pigment and Rice Exporter Stocks to Buy Before You Invest
A short checklist keeps the research consistent when you screen branded medicine, blue pigment and rice exporter stocks and shortlist branded medicine, blue pigment and rice exporter stocks to buy.
- Compare each stock’s P/E with its industry P/E, which differs by company here.
- Check revenue growth, operating margin and cash flow together.
- Check whether revenue growth is turning into profit growth, not only sales.
- Read operating cash flow against capital expenditure to see how growth is funded.
- Watch debt to equity and interest cover before sizing a position.
- Spread exposure across companies and business lines instead of one demand cycle.
Risks to Consider Before Investing in Branded Medicine, Blue Pigment and Rice Exporter Stocks
- Consumer demand: Spending patterns can shift sales between quarters.
- Input costs: Changes in raw material prices can affect margins.
- Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.
Download the Univest iOS App or Univest Android App to track Alkem, Ultramarine and LT Foods live.
Final Take: Which Stock Has the Strongest Roadmap?
These three healthcare, chemicals and consumer stocks cover branded medicines, pigments and rice. Alkem leads on FY26 operating margin and return on equity; Ultramarine leads on Q1 FY27 revenue growth and FY26 net profit growth; LT Foods leads on FY26 revenue growth.
Across branded medicine, blue pigment and rice exporter stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the branded medicine, blue pigment and rice exporter stocks to buy discussed here.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
FAQs on Branded Medicine, Blue Pigment and Rice Exporter Stocks
Which are the best branded medicine, blue pigment and rice exporter stocks in India with a strong roadmap?
Ans. Alkem Laboratories, Ultramarine & Pigments and LT Foods stand out for their roadmaps in branded medicines, pigments and rice. FY26 revenue growth was 13.7% at Alkem, 11.2% at Ultramarine and 25.7% at LT Foods, and return on equity ranges from 9.29% to 16.66%.
Is Alkem Laboratories a good stock to buy now?
Ans. Alkem Laboratories has a debt to equity ratio of 0.15, a return on equity of 16.66% and a P/E of 28.43 against an industry P/E of 37.59. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.
What is the P/E ratio of Alkem, Ultramarine and LT Foods?
Ans. The P/E ratio is 28.43 for Alkem (industry 37.59), 12.67 for Ultramarine (industry 36.60) and 21.98 for LT Foods (industry 34.85). All of them trade below the industry multiple.
Which of these branded medicine, blue pigment and rice exporter stocks has the highest return on equity?
Ans. Alkem Laboratories has the highest return on equity at 16.66%, followed by LT Foods at 13.83% and Ultramarine & Pigments at 9.29%.
What are the risks of investing in branded medicine, blue pigment and rice exporter stocks?
Ans. The main risks are consumer demand, input costs and quarterly trends. Spending patterns can shift sales between quarters.
How did Alkem, Ultramarine and LT Foods perform in Q1 FY27?
Ans. Alkem Laboratories reported revenue of Rs 3,892.90 crore, up 11.0% year on year. Ultramarine & Pigments reported revenue of Rs 245.68 crore, up 31.2% year on year, and net profit rose 56.5% to Rs 31.59 crore. LT Foods reported revenue of Rs 3,161.29 crore, up 26.4% year on year, and net profit rose 8.9% to Rs 183.45 crore.
Do branded medicine, blue pigment and rice exporter stocks pay dividends?
Ans. Yes, all three companies pay dividends. The dividend yield is 1.01% for Alkem, 1.50% for Ultramarine and 0.74% for LT Foods, based on dividends declared for FY26.
How can I invest in branded medicine, blue pigment and rice exporter stocks in India?
Ans. You can buy branded medicine, blue pigment and rice exporter stocks through a demat and trading account on NSE or BSE after checking each company’s financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.
